Schweitzer, K., What does the rise of GLP-1 drugs mean for bariatric surgery? JAMA , Jan
Patients should seek prompt medical guidance for severe or persistent vomiting, signs of dehydration, severe abdominal pain, fainting, symptoms of low blood sugar, inability to keep fluids down, worsening constipation with pain or bloating, or any symptom that feels unsafe
Masteron and Retatrutide: The Hardening Agent Masteron (Drostanolone) brings unique properties to the Retatrutide stacking equation
And for the full list of side effects, look at the package insert that comes with your medication (find those here for Zepbound, Mounjaro, Wegovy, and Ozempic)
If youve been using a compounded GLP-1, this means youll likely need to switch to a brand-name GLP-1
This article explains the evidence around stopping GLP-1 therapy, what to expect when treatment ends, and how to discontinue safely under medical supervision in line with UK clinical guidance